ArticleBiz.com :: Free article content
Authors: Maximum article exposure. Publishers: Reprintable article content.  
BROWSE ARTICLES
ArticleBiz.com Home
Featured Articles
Recently Added Articles
Most Viewed Articles
Article Comments
Advanced Article Search
AUTHORS
Submit Article
Check Article Status
Author TOS
PUBLISHERS
RSS Article Feeds
Terms of Service

Anti-obesity medication Acomplia for weight loss
Home :: Health & Fitness :: Weight-Loss
By: Katie Lynn Email Article
Word Count: 738 Digg it | Del.icio.us it | Google it | StumbleUpon it

  

Acomplia (rimonabant) – Anti-obesity medication for safe and effective weight loss

Acomplia is an anti-obesity drug manufactured by Sanofi Aventis. It is used to aid obese and overweight patients with associated risk factors of high diabetes or high cholesterol lose weight. Acomplia is approved for use within the European Union and has been available to patients in the UK since June 2006. This anti-obesity medicine is yet to be approved by the FDA for the US.

About Acomplia

If you want to know how Acomplia helps in weight loss, the following explanation will help you out.

Acomplia as an anti-obesity medicine works by blocking receptors called cannabinoid-1 receptors (CB1). These receptors are found in several parts of the body such as in the brain, fat tissue, digestive system, liver, and muscles. When these receptors are over activated, they lead to an increase in appetite, cravings for food and fat build-up.

Acomplia blocks these CB1 receptors and leads to a decrease in appetite, and allows you to control hunger which consequently results in significant weight loss.

Strength and Ingredients of Acomplia

Acomplia contains rimonabant as it active ingredient, which is a type of medicine known as a cannabinoid-1 receptor antagonist and works as an appetite suppressant. This anti-obesity medicine is available in 10mg and 20mg dosage and is to be taken as prescribed by the doctor.

Side effects of Acomplia

There are very few side effects of Acomplia and they are temporary and transient in nature. Some of the side effects of this anti-obesity medication include nausea, dizziness, diarrhoea, vomiting, hypoglycaemia, anxiety, and mood swings.

Online availability of Acomplia

If you want to get Acomplia online but are not sure if you will get it or not, read on. Most people can get this anti-obesity medicine without any problem. However, if you have certain medical conditions because of which Acomplia becomes unsafe for you, you will not be able to get it online or offline.

If you are obese i.e. your BMI is over 30, or are overweight and your BMI is between 27 and 30 and you are at risk of medical conditions related to weight or body fat, such as diabetes, high cholesterol, or hypertension, you can get Acomplia prescription online.

If you meet any of the following criteria, you will not get Acomplia online :

  • over 75 years of age
  • decreased liver function
  • decreased kidney function
  • had a heart attack or stroke in the last six months
  • history of depression or suicidal thoughts
  • epilepsy
  • allergy to rimonabant or any other ingredient of Acomplia
  • Severely decreased liver and/or kidney function
  • Uncontrolled serious psychiatric illness
  • Major depressive illness
  • People taking antidepressant medicines
  • Pregnancy
  • Breastfeeding
Note:

Page 1 of 2 :: First | Last :: Prev | 1 2 | Next

Webmaster associated with online pharmacy "OnlineClinic.co.uk" this site provides information about Acomplia & Obesity. Buy Acompla the Weight loss Drug for Obesity treatment.

Article Source: http://www.ArticleBiz.com

This article has been viewed 182 times.

Rate Article
Rating: 0 / 5 stars - 0 vote(s).

Article Comments
There are no comments for this article.

Leave A Reply
 Your Name
 Your Email Address [will not be published]
 Your Website [optional]
 What is seven + eight? [tell us you're human]
Notify me of followup comments via email


Related Articles


Copyright © 2009 by ArticleBiz.com. All rights reserved.

Terms of Service | Privacy Policy | Contact Us | Submit Article | Editorial